Who
Ellen M. Zane
Director
Company insider
Files Form 4 as: Director, Synchrony Financial; Director, GMR Solutions; Director, Haemonetics; Director, Boston Scientific; Director, Azenta; Director, Parexel International; Director, Press Ganey Holdings; Director, Lincare Holdings.
In numbers
- Trades disclosed
- 152
- Buys
- 1
- Sells
- 5
- Bought
- $21K
- Sold
- $5.0M
- Companies
- 8
- Companies where not an officer
- 8
- First trade
- 14 Dec 2006
- Last trade
- 30 Sep 2026
- Last filed
- 2 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 30 Sep 2026filed 2 Oct 2026 | SYF Synchrony FinancialConsumer & Specialty Finance | SEC FORM 4 Code A | $60K846 at $70.97 | filing |
| 26 Aug 2026filed 28 Aug 2026 | GMRS GMR Solutionsoption or derivative · Trucking & Logistics | SEC FORM 4 Code A | —976 at $0.00 | filing |
| 26 Aug 2026filed 28 Aug 2026 | GMRS GMR Solutionsoption or derivative · Trucking & Logistics | SEC FORM 4 Code A | —976 at $0.00 | filing |
| 17 Aug 2026filed 19 Aug 2026 | SYF Synchrony FinancialConsumer & Specialty Finance | SEC FORM 4 Code A | $1,13114 at $80.75 | filing |
| 17 Aug 2026filed 19 Aug 2026 | SYF Synchrony FinancialConsumer & Specialty Finance | SEC FORM 4 Code A | $1,13114 at $80.75 | filing |
| 24 Jul 2026filed 28 Jul 2026 | HAE HaemoneticsMedical Devices | SEC FORM 4 Code A | —2,538 | filing |
| 24 Jul 2026filed 28 Jul 2026 | HAE HaemoneticsMedical Devices | SEC FORM 4 Code A | —2,538 | filing |
| 1 Jul 2026filed 6 Jul 2026 | GMRS GMR Solutionsoption or derivative · Trucking & Logistics | SEC FORM 4 Code A | —9,972 at $0.00 | filing |
| 1 Jul 2026filed 6 Jul 2026 | GMRS GMR Solutionsoption or derivative · Trucking & Logistics | SEC FORM 4 Code A | —9,972 at $0.00 | filing |
| 30 Jun 2026filed 2 Jul 2026 | SYF Synchrony FinancialConsumer & Specialty Finance | SEC FORM 4 Code A | $60K789 at $76.05 | filing |
| 30 Jun 2026filed 2 Jul 2026 | SYF Synchrony FinancialConsumer & Specialty Finance | SEC FORM 4 Code A | $60K789 at $76.05 | filing |
| 15 May 2026filed 19 May 2026 | SYF Synchrony FinancialConsumer & Specialty Finance | SEC FORM 4 Code A | $99914 at $71.38 | filing |
| 15 May 2026filed 19 May 2026 | SYF Synchrony FinancialConsumer & Specialty Finance | SEC FORM 4 Code A | $99914 at $71.38 | filing |
| 7 May 2026filed 11 May 2026 | BSX Boston ScientificMedical Devices | SEC FORM 4 Code A | —3,800 at $0.00 | filing |
| 7 May 2026filed 11 May 2026 | BSX Boston ScientificMedical Devices | SEC FORM 4 Code A | —3,800 at $0.00 | filing |
| 31 Mar 2026filed 2 Apr 2026 | SYF Synchrony FinancialConsumer & Specialty Finance | SEC FORM 4 Code A | $60K883 at $68.02 | filing |
| 31 Mar 2026filed 2 Apr 2026 | SYF Synchrony FinancialConsumer & Specialty Finance | SEC FORM 4 Code A | $60K883 at $68.02 | filing |
| 17 Feb 2026filed 19 Feb 2026 | SYF Synchrony FinancialConsumer & Specialty Finance | SEC FORM 4 Code A | $1,01214 at $72.31 | filing |
| 17 Feb 2026filed 19 Feb 2026 | SYF Synchrony FinancialConsumer & Specialty Finance | SEC FORM 4 Code A | $1,01214 at $72.31 | filing |
| 31 Dec 2025filed 5 Jan 2026 | SYF Synchrony FinancialConsumer & Specialty Finance | SEC FORM 4 Code A | $55K660 at $83.43 | filing |
News
Boston Scientific Corporation $BSX Stock: Goelzer Investment Management Inc. Raises PositionBSX · dailypolitical.com · 17 Oct 2026Boston Scientific (NYSE:BSX) Upgraded at BarclaysBSX · dailypolitical.com · 10 Oct 2026Financial Contrast: Sysmex (OTCMKTS:SSMXY) and Boston Scientific (NYSE:BSX)BSX · themarketsdaily.com · 10 Oct 2026
0 headlines in the last 90 days name Ellen M. Zane; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.